CIK 0001606636
SEC CIK 1606636At a glance
Insiders at CIK 0001606636 have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.
Largest recent trade: Froehlich Robert J, HGLB's Director, spent $32.9K of their own money on 3,600 shares at $9, growing their stake 138%.
Most active filer: Froehlich Robert J, with 35 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for CIK 0001606636, newest firstFroehlich Robert J, HGLB's Director, spent $9.4K of their own money on 999 shares at $9, growing their stake 16%.
Froehlich Robert J, NHF's Director, spent $9K of their own money on 632 shares at $14, growing their stake 225%.
Froehlich Robert J, HGLB's Director, spent $32.9K of their own money on 3,600 shares at $9, growing their stake 138%.
Froehlich Robert J, HGLB's Director, spent $6.9K of their own money on 758 shares at $9, growing their stake 29%.
Froehlich Robert J sold $5.9K of NHF, trimming their stake 71%.
Froehlich Robert J, NHF's Director, spent $5.9K of their own money on 700 shares at $8, growing their stake 249%.
Froehlich Robert J, HGLB's Director, spent $6.1K of their own money on 1,000 shares at $6, growing their stake 62%.
Froehlich Robert J, HFRO's Director, spent $5.9K of their own money on 697 shares at $8, growing their stake 135%.
Froehlich Robert J, HGLB's Director, spent $1.6K of their own money on 182 shares at $9, growing their stake 13%.
Froehlich Robert J, HFRO's Director, spent $1.7K of their own money on 130 shares at $13, growing their stake 34%.
Froehlich Robert J, NHF's Director, spent $1.6K of their own money on 97 shares at $17, growing their stake 53%.
Froehlich Robert J, NHF's Director, spent $4.2K of their own money on 184 shares at $23, opening a brand-new position.
Froehlich Robert J, PHMD's Director, spent $110 of their own money on 110 shares at $1, growing their stake 4%.
Froehlich Robert J, PHMD's Director, spent $250 of their own money on 250 shares at $1, growing their stake 11%.
Froehlich Robert J, PHMD's Director, spent $2.4K of their own money on 2,355 shares at $1, opening a brand-new position.
About CIK 0001606636 insider activity
This page tracks every recent Form 4 filed for CIK 0001606636 with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is CIK 0001606636 insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for CIK 0001606636 usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.